Wolverine Asset Management’s Intersect ENT, Inc XENT Stock Holding History

Wolverine Asset Management’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-8,850	Closed	-$247K	–	2780
2022 Q1	$247K	Hold	8,850	–	–	﹤0.01%	1125
2021 Q4	$241K	Buy	8,850 +550	+7%	+$14.9K	﹤0.01%	1187
2021 Q3	$225K	Buy	+8,300	New	+$205K	﹤0.01%	1149

Wolverine Asset Management's XENT Position: Q2 2022 in Review

Wolverine Asset Management sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 8,850 shares — an estimated $247K sold.

Wolverine Asset Management first reported a position in XENT in Q3 2021 and held it in 3 quarters. The position peaked at $247K in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

Wolverine Asset Management reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
Wolverine Asset Management sold 8,850 Intersect ENT, Inc shares in Q2 2022, an estimated $247K.
Wolverine Asset Management first reported a position in Intersect ENT, Inc in Q3 2021 and held it in 3 quarters.
Wolverine Asset Management's Intersect ENT, Inc position peaked at $247K in Q1 2022.
0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Wolverine Asset Management's 13F filing for Q2 2022, filed 3 Aug 2022.